Latest News
Kaiser Permanente reports study findings showing significant cost savings
7 May 2026 - Health care provider Kaiser Permanente said on Wednesday that it has commissioned Milliman, a global actuarial and professional services consulting firm, to conduct a study comparing Kaiser Permanente's 2023 prescription drug costs ...
Partner Therapeutics' BIZENGRI receives FDA Commissioner's National Priority Voucher for NRG1 fusion-positive cholangiocarcinoma
7 May 2026 - Biotechnology company Partner Therapeutics Inc (PTx) announced on Wednesday that the US Food and Drug Administration (FDA) has awarded a Commissioner's National Priority Voucher (CNPV) pilot program voucher for BIZENGRI (zenocutuzum...
Diakonos Oncology's DOC1021 granted US FDA Fast Track Designation for unresectable or metastatic cutaneous melanoma
7 May 2026 - Clinical-stage biotechnology company Diakonos Oncology Corp announced on Wednesday that the US Food and Drug Administration (FDA) has granted Fast Track designation to DOC1021 (dubodencel), its first-in-class, patient-derived double-load...
Racura Oncology identifies mechanism of action for (E,E)-bisantrene
...
Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline
6 May 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) announced on Wednesday that it has agreed to fully acquire Perfuse Therapeutics Inc, strengthening its pharmaceutical pipeline and reinforcing its strategic ...